[PDF] Top 20 Acute myeloid leukemia in elderly patients: experience of a single center

... Acute myeloid leukemia (AML) is a disease predominantly of older ...Treatment of AML in the elderly is complicated not only by comorbidities but also by the high ... See full document

... with Acute Myeloid Leukaemia (AML), when compared to younger patients with the same disease, have a poor prognosis and represent a discrete population in terms of disease biology, ... See full document

... ml of each BM samples was collected in a syringe containing sodium ...gain of chromosomal material or the same structural aberra- tion or as at least three BM cells showing loss of the same ... See full document

... group of diseases with high ...the experience of a Brazilian center in respect to acute leukemia patients who received a bone marrow or peripheral blood allograft ... See full document

... manifestations of hypernatremia vary fully depending on the underlying ...among patients with extracellular luid volume de- crease, whereas the initial presentation of diabetes insipidus is polyuria, ... See full document

... AKI in critically ill patients[23, ...risk of AKI in the ...damage in AKI also involves inflamma- tory responses including immune cells, cytokines ...frail patients might be ... See full document

... Cluster of differentiation 11b (CD11b) is a kind of cell surface receptor that are selectively expressed on leukocytes, which is also named as integrin alpha M (ITGAM), complement com- ponent 3 receptor ... See full document

... time of the AML-M4 diagnosis our patient pre- sented a karyotype with three atypical clonal abnormalities, ...abnormalities in- volved four breakpoints (1p32, ...disrupted in a few AML M4 cases. ... See full document

... III-IV toxicities were less common in the reduced inten- sity group. This trial was stopped early due to a slow inclu- sion of patients. The authors concluded that reduced intensity conditioning had ... See full document

... analysis of samples from Penn was performed by the Center for Personalized Diagnostics, using an amplicon-based custom targeted next-generation sequencing panel for 33 hematologic malignancy-associated ... See full document

... cases of acute myeloid leukemia in ...study of 11 listed Brazilian centers that treat acute myeloid leukemia and perform bone marrow ...charts of ... See full document

... disorder, in which the predominant cells share morphologic and immunophenotypic features from both Langerhans and non-Langerhans cell ...most patients present multiple asymptomatic papulonodules with a ... See full document

... effect of thein vivo treatment of mice with demethylating agents after allo-HSCT, mice were transplanted with T cell depleted bone marrow following ablative ...recovery of the blood counts the mice ... See full document

... study in a single ...strategy of the patients changed over ...incompleteness of the data and the possibility of residual confounding cannot be ...about patients who ... See full document

... prognosis of acute myeloid leukemia (AML), among which molecular genetic abnormalities are developed increasingly, however, accurate prediction for newly diagnosed AML patients remains ... See full document

... risk of myelosuppression. Thus, fluoroquinolones became the treatment of choice worldwide, due to their good oral tolerability, broad antimicrobial spectrum, bactericidal activity, ability to preserve ... See full document

... IIMM patients are routinely monitored by measuring their serum immunoglobulin and urine light chains – a logical step would be to supplement, or replace, the urine assays with serum FLC measurements, as has ... See full document

... size of the duplica- tion varied from 21 to 87 base pairs (mean: 57 base pairs) and only two cases had two peaks, showing a very heterogeneous ...0.44) in respect to the size of the duplication and ... See full document

... endpoint of our study was OS, which was deined as the period between the date of irst recurrence diagnosis and death due to the disease/last medical ...date of irst recurrence diagnosis and the date ... See full document

... useful in systematically identifying commonly reported genes and pathways in the heterogeneous disease of ...inclusion of all pertinent studies into the analysis and is accompanied by an ... See full document